Replacement Heart Update
July 11, 2001
According to Drs. Gray and Dowling the patient was
removed from the ventilator on Monday afternoon and was able to
converse with his family and physicians and enjoyed sitting up in
a chair listening to his favorite music. He was returned to the
operating room on Monday to drain fluid, which had accumulated around
the battery pack. This procedure lasted approximately 30 minutes
and the patient returned to his room where he rested comfortably
for the remainder of the evening. He later enjoyed watching a movie
with his wife.
The patient requested that the physicians relay his
sincere appreciation for the many prayers he has received from around
the world. He is looking forward to expressing his gratitude personally.
On Tuesday, the patients chest tube drained
an increased amount of fluid and blood. The surgeons have evaluated
the increased drainage and have determined that a return trip to
the operating room is not currently warranted as the oozing appears
to be a result of the anticoagulation therapy he is receiving as
part of his treatment protocol. Late Tuesday evening the patient
experienced fatigue and the decision was made to place him back
on the ventilator.
The device continues to function flawlessly.
Today his condition remains critical but stable and
he is resting comfortably. He is communicating with his family and
friends and is continuing his exercise program.
Future Media Inquiries
Jewish Hospital, the University of Louisville and
ABIOMED have indicated that they would enforce a quiet period
with regard to the recent implant of the AbioCor Implantable Replacement
Heart. This quiet period is intended to protect and respect the
privacy and confidentiality of the patient and his family. We urge
members of the media to understand and respect this policy.
In recognition of the numerous calls and inquiries
concerning the technical facets of the AbioCor and of the surgical
procedure, and the well wishes sent to the patient and
his family, Jewish Hospital, the University of Louisville and ABIOMED
have agreed that we will receive questions via our media center
at (502) 561-5447. Answers to questions will be obtained from appropriate
parties at the various institutions, and questions and answers will
be posted on our websites at www.heartpioneers.com and www.abiomed.com.
Please note that we will not respond to questions regarding the
patients clinical condition, or to questions that would infringe
upon the privacy of the patient or his family.
We appreciate very much the interest being shown
in this project. We also hope that members of the media can appreciate
and respect our desire to conduct this clinical trial in an ethical
manner, respecting above all the dignity and privacy of the patient
and his family.
Printer friendly version
Acrobat Reader Required)